Method for purifying nanoparticles, nanoparticle composition and method for producing nanoparticle composition
By employing a solvent and associative ligand with specific properties, the method stabilizes the α phase of quantum dots at lower temperatures, addressing the limitations of high-temperature synthesis and phase instability in existing methods.
Patent Information
- Application Number
- JP2023083370
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-19
- Publication Date
- 2024-11-29
AI Technical Summary
Existing methods for synthesizing quantum dots with a perovskite crystal structure require high temperature conditions, limiting industrial application and result in a gradual phase change from the α phase over time.
A method involving the use of a solvent with a predetermined dielectric constant and an associative ligand with a polar group to selectively increase the content ratio of a predetermined crystal structure, facilitating the formation and stabilization of the α phase at lower temperatures.
Enables the purification of nanoparticles to achieve and maintain the α phase under lower temperature conditions, ensuring stability and phase consistency over time.
Smart Images

Figure 2024166933000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates to methods for purifying nanoparticles, nanoparticle compositions, and methods for making nanoparticle compositions. [Background technology]
[0002] Quantum dots with a perovskite crystal structure have a narrow full width at half maximum in the spectral sensitivity characteristics and exhibit high color purity, so they are known to be applied to organic electroluminescence materials, quantum dot luminescent materials, and solar cell materials. In addition, they have the advantage that it is easy to provide materials that respond to light in a wide wavelength range, because the absorption and emission wavelengths can be controlled by the halogen composition.
[0003] Quantum dots with a perovskite crystal structure are known to take on a variety of crystal phases depending on the synthesis and storage conditions (Non-Patent Document 1). The light-emitting and power-generating properties are greatly affected by the type of crystal phase. The α phase has the best properties, but because the α phase is a high-temperature stable phase, it is difficult to selectively produce it using conventional synthesis methods.
[0004] In Non-Patent Document 2, quantum dots having an α phase are obtained by synthesizing quantum dots while reacting with oleylamine hydroiodide at a high temperature of 260°C. [Prior art documents] [Non-patent literature]
[0005] [Non-Patent Document 1] Phys.Rev.Materials 3,113605 [Non-Patent Document 2] Angew.Chem.Int.Ed.2018,57,9083-9087 Summary of the Invention [Problem to be solved by the invention]
[0006] However, the synthesis method described in Non-Patent Document 2 requires a high temperature condition of 260° C., which limits its industrial application. In addition, the quantum dots obtained by the synthesis method described in Non-Patent Document 2 have a problem in that the crystal phase gradually changes from the α phase over time.
[0007] The present invention has been made in view of the above problems, and aims to provide a method for purifying nanoparticles that can obtain the α-phase at lower temperatures, and a nanoparticle composition that can maintain the α-phase over time. [Means for solving the problem]
[0008] A method for purifying nanoparticles according to an embodiment of the present invention includes the steps of preparing nanoparticles having a perovskite crystal structure as an allotrope and exhibiting a plurality of crystal structures; A step of preparing a ligand liquid including a solvent exhibiting a relative dielectric constant of a predetermined value or less, and an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity relative to the main chain, and self-associating in the solvent; contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion. The step of adjusting the nanoparticle dispersion liquid includes a step of selectively increasing a content ratio of a predetermined crystal structure among the plurality of crystal structures.
[0009] In addition, a method for producing a nanoparticle composition according to an embodiment of the present invention includes the steps of preparing nanoparticles having a perovskite crystal structure as an allotrope and exhibiting a plurality of crystal structures; A step of preparing a ligand liquid including a solvent exhibiting a relative dielectric constant of a predetermined value or less, and an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity relative to the main chain, and self-associating in the solvent; contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion; The step of adjusting the nanoparticle dispersion liquid includes a step of selectively increasing a content ratio of a predetermined crystal structure among the plurality of crystal structures.
[0010] In addition, the nanoparticle composition according to the embodiment of the present invention comprises nanoparticles having a perovskite crystal structure as an allotrope, an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity greater than that of the main chain; At least a portion of the associative ligands are coordinated to the nanoparticles via the polar groups so as to alter the crystal structure of the nanoparticles.
[0011] In addition, the nanoparticle composition according to the embodiment of the present invention includes a solvent having a relative dielectric constant equal to or less than a predetermined value, Nanoparticles containing a perovskite crystal structure as an allotrope; A main chain containing a plurality of carbon atoms and a plurality of ligands having polar groups that are more polar than the main chain, The plurality of ligands include a first component that forms a reverse micelle-like structure in the solvent; and a second component coordinated to the particle surface of the nanoparticle. Effect of the Invention
[0012] According to the present invention, a method for purifying nanoparticles that can obtain the α-phase under lower temperature conditions can be provided, and a nanoparticle composition that can maintain the α-phase over time can be provided. [Brief description of the drawings]
[0013] [Figure 1] FIG. 1 is a process diagram showing (a) a method for producing a nanoparticle composition and (b) a method for purifying nanoparticles according to a first embodiment. [Diagram 2] FIG. 2 is a diagram showing a schematic configuration of nanoparticles P and ligand liquid Q (60-1 to 60-4) according to the first embodiment. [Diagram 3] FIG. 2 shows a schematic structure of a nanoparticle composition according to a second embodiment. [Figure 4] FIG. 1 shows a schematic structure of a nanoparticle composition according to a third embodiment. [Diagram 5] FIG. 13 is a diagram showing a schematic structure of a wavelength conversion layer containing a nanoparticle composition and a display element according to a fourth embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] Preferred embodiments of the present invention will be described in detail below with reference to the drawings. The dimensions, materials, shapes, relative positions, and so forth of the components described in these embodiments are not intended to limit the scope of the present invention.
[0015] <First embodiment> The production method and composition of a nanoparticle composition according to the first embodiment, as well as a method for purifying nanoparticles, will be described with reference to FIGS.
[0016] As shown in FIG. 1(a), the method 1000 for producing a nanoparticle composition according to the first embodiment includes at least steps S103, S105, S107, and S109 between a start step S101 and a finish step S111.
[0017] (S103) Step S103 is a step of preparing nanoparticles A that contain a perovskite crystal structure as an allotrope and exhibit a plurality of crystal structures.
[0018] (S105) Step S105 is a step of preparing a ligand solution B containing a solvent 10 exhibiting a relative dielectric constant equal to or lower than a predetermined value, and an associative ligand 60 having a main chain 40 containing a plurality of carbon atoms and a polar group 50 having polarity greater than that of the main chain 40, and which self-associates in the solvent 10.
[0019] (S107, S109) Step S107 is a step of preparing a nanoparticle dispersion C by contacting nanoparticles P with a ligand liquid Q, and includes a step S109 of selectively increasing the ratio of the content of a specific crystal structure among multiple crystal structures.
[0020] The method 1000 for producing a nanoparticle composition according to this embodiment includes a step S109 for selectively increasing the content ratio of a specific crystal structure among multiple crystal structures corresponding to nanoparticles P, and therefore may be referred to as a method 1000 for purifying nanoparticles.
[0021] Regarding the mechanism by which the content ratio of a specific crystal structure is selectively increased in the method 1000 for producing a nanoparticle composition, the present inventors believe that the mechanism is as follows.
[0022] First, the premise is that nanoparticles P, which contain a perovskite-type crystal structure as an allotrope, are unstable to polar substances, and therefore, when they are dispersed and supported in a solvent, they need to be dispersed in a solvent that exhibits a relative dielectric constant below a certain value (a low-polarity solvent).
[0023] Next, a case will be considered in which, with the intention of protecting nanoparticles P that contain a perovskite-type crystal structure as an allotrope, a ligand having a polar group is coordinated to the particle surface of nanoparticles P.
[0024] Ligands having polar groups have low affinity for low-polarity solvents, and therefore cannot be applied in large quantities to nanoparticles P. On the other hand, associative ligands 60 that exhibit self-association in relation to a solvent have their apparent polarity reduced by association between polar groups 50, and can have polar sites present at high concentrations even in low-polarity solvents (ligand liquid Q). In this specification, the self-association of a ligand refers to the property of forming a reverse micelle-like structure in which a non-polar group faces the solvent side, due to at least one of the association of a single ligand itself and the association of multiple related ligands.
[0025] When the ligand liquid Q is brought into contact with the nanoparticles P, at least a part of the self-associated associative ligands 60 in the solvent 10 is dissociated into a component 60-a, and a component 60-b that maintains the self-association is generated. The dissociated ligands 60-a of the associative ligands 60 are considered to be coordinated to the particle surface of the nanoparticles P. In other words, at least a part of the nanoparticles P is protected so as to be incorporated into the associated part of the associative ligands 60. A plurality of polar groups 50 of the associative ligands 60 are coordinated to the particle surface of the nanoparticles P at once. The present inventors presume that this sudden coordination is the driving force that induces a change to the α phase, which is a high-temperature stable phase.
[0026] (self-meeting) In this embodiment, self-association means that at least some of the polar groups 50 associate with each other through electrostatic interaction in a solvent 10 exhibiting a specific dielectric constant equal to or less than a certain value. The polar groups 50 do not necessarily have to interact directly with each other, and a small amount of polar substance such as water may be present between them. Furthermore, the self-association may be an intermolecular association (60-1) or an intramolecular association (60-2) as shown in FIG. 2(b). Furthermore, a case where different types of polar groups associate with each other through electrostatic interaction and form an inverted micelle-like structure with respect to a common solvent 10 is also considered to be self-associated.
[0027] (Nanoparticles) The nanoparticles P in this embodiment are nanoparticles containing nanocrystals as allotropes having a perovskite crystal structure with A site (monovalent cation), B site (divalent cation), and X site (monovalent anion including halide anion) as constituents. The perovskite crystal structure is alternatively referred to as a perovskite structure, an ABX3 crystal structure, or an ABX3 structure. The double perovskite crystal structure represented by A2B1B2X6 is also included in the perovskite crystal structure. In this specification, the nanoparticles P may be alternatively referred to as luminescent nanoparticles, luminescent nanocrystals, photoresponsive nanocrystals, or quantum dots.
[0028] The average particle size of the nanoparticles is preferably 1 nm or more and 30 nm or less, more preferably 2 nm or more and 25 nm or less. If the average particle size is less than 1 nm, the stability may be insufficient. If the average particle size is more than 30 nm, the dispersibility in the medium may be insufficient.
[0029] [A site of perovskite structure] A monovalent cation is used at the A site. The monovalent cation used at the A site is the ammonium cation (NH4 + ), and alkylammonium cations with carbon atoms of 6 or less, formamidinium cations (HC(NH2)2 + ), guanidinium cation (C(NH2)3 + ), imidazolium cation, pyridinium cation, pyrrolidinium cation, and other nitrogen-containing organic compound cations; and lithium cation (Li + ), sodium cation (Na + ), potassium cation (K + ), rubidium cation (Rb + ), and the cesium cation (Cs + ) and other alkali metal cations.
[0030] These monovalent cations employed in the A site have a small ionic diameter and are small enough to fit into the crystal lattice, enabling the perovskite compound to form stable three-dimensional crystals.
[0031] A preferred example of an alkylammonium cation having 6 or less carbon atoms is a methylammonium cation (CH3NH3 + ), ethylammonium cation (C2H5NH3 + ), propylammonium cation (C3H7NH3 + ) etc.
[0032] From the viewpoint of obtaining high luminous efficiency, it is preferable to use at least one of methylammonium cation, formamidinium cation, and cesium cation as the A site, and from the viewpoint of suppressing color change, it is more preferable to use cesium cation as the A site. Two or more kinds of these monovalent cations employed as the A site may be used in combination.
[0033] When the A site is a cesium cation, the raw material for nanoparticle synthesis may be a cesium salt. As the cesium salt, cesium chloride, cesium bromide, cesium iodide, cesium hydroxide, cesium carbonate, cesium hydrogen carbonate, cesium bicarbonate, cesium formate, cesium acetate, cesium propionate, cesium pivalate, or cesium oxalate may be appropriately used. Among these cesium salt candidates, an appropriate one may be used depending on the synthesis method.
[0034] When the A site is another alkali metal cation, a salt in which the cesium element of the above-mentioned cesium compound is replaced with another alkali metal cation element can be used as the raw material.
[0035] When the A site is a nitrogen-containing organic compound cation such as a methylammonium cation, for example, a neutral compound other than a salt such as methylamine can be used as a raw material. Two or more of these raw materials may be used in combination.
[0036] [Perovskite crystal structure B site] The B site of the perovskite crystal structure employs a divalent cation including a divalent transition metal cation or a divalent typical metal cation.
[0037] The divalent transition metal cation is the scandium cation (Sc 2+ ), titanium cation (Ti 2 +), vanadium cation (V 2+ ), chromium cation (Cr 2+ ), manganese cation (Mn 2+ ), iron cation (Fe 2+ ), cobalt cation (Co2+ ), nickel cation (Ni 2+ ), copper cation (Cu 2+ ), palladium cation (Pd 2+ ), europium cation (Eu 2+ ), ytterbium cation (Yb 2+ ) will be adopted.
[0038] The divalent typical metal cation is the magnesium cation (Mg 2+ ), calcium cation (Ca 2+ ), strontium cation (Sr 2+ ), barium cation (Ba 2+ ), zinc cation (Zn 2+ ), cadmium cation (Cd 2+ ), germanium cation (Ge 2+ ), tin cation (Sn 2+ ), lead cation (Pb 2+ ) may be adopted.
[0039] Among these divalent cations, divalent typical metal cations are preferred from the viewpoint of growing stable three-dimensional crystals, tin cations or lead cations are more preferred, and lead cations are particularly preferred from the viewpoint of obtaining high luminescence intensity. Two or more of these divalent cations may be used in combination, and the perovskite crystal structure may be a so-called double perovskite structure.
[0040] When the B site is a lead cation, the raw material for nanoparticle synthesis includes lead compounds, and an appropriate one can be used depending on the synthesis method. As the lead compound, lead chloride, lead bromide, lead iodide, lead oxide, lead hydroxide, lead sulfide, lead carbonate, lead formate, lead acetate, lead 2-ethylhexanoate, lead oleate, lead stearate, lead naphthenate, lead citrate, lead maleate, and lead acetylacetonate are adopted. When the B site is another divalent metal cation, a salt in which the lead element of the above-mentioned lead compound is replaced with another divalent metal cation element can be used as the raw material. Two or more of these raw materials may be used in combination.
[0041] [X site of perovskite crystal structure] X in the perovskite crystal structure is a monovalent anion including a halide anion. The halide anion is a fluoride anion (F - ), chloride anion (Cl - ), bromide anion (Br - ), iodide anion (I - Among them, chloride anion, bromide anion, or iodide anion are preferred because they form stable three-dimensional crystals and emit strong light in the visible light range. The color of the emitted light is blue when chloride anion is used, green when bromide anion is used, and red when iodide anion is used.
[0042] Two or more kinds of halide anions may be used in combination. In particular, when chloride anions, bromide anions, and iodide anions are used in combination, the emission wavelength of the nanoparticles can be set to a desired wavelength depending on the content ratio of the anion species. That is, in particular, when chloride anions, bromide anions, and iodide anions are used in combination, it is preferable because it is possible to obtain an emission spectrum that covers almost the entire range of visible light from blue to red while maintaining a narrow full width at half maximum depending on the content ratio of the anion species.
[0043] The X site may contain a monovalent anion other than a halide anion. Such a monovalent anion other than a halide anion may be a cyanide anion (CN - ), thiocyanate anion (SCN - ), isothiocyanate anion (CNS - As for the raw materials for nanoparticle synthesis, salts with counter cations at the A and B sites, such as cesium chloride and lead bromide, and salts with other cations can be selected appropriately according to the synthesis method.
[0044] The nanoparticles P in this embodiment can be produced by the following process. For example, the hot injection method, in which raw material liquids are mixed at high temperature and then rapidly cooled after the generation of fine particles to obtain a stable product, and the ligand-assisted reprecipitation method, in which fine particles are obtained by reprecipitation utilizing the difference in miscibility of the product with the solvent, are adopted.
[0045] Also, a room temperature synthesis method is used in which a mixture of A-site raw materials and B-site raw materials, which are non-halogenated and do not contain X-site components, is mixed with a separately prepared X-site raw material liquid under mild conditions at around room temperature to obtain fine particles.Furthermore, this method is used in a mechanochemical method in which solid raw materials are reacted by mechanical mixing such as milling or ultrasonic treatment to obtain product fine particles, and an in situ synthesis method in which a raw material liquid is applied to a substrate and then directly crystallized to obtain a reaction product.
[0046] By allowing the ligands described below to coexist during the production of the nanoparticles P, the ligands can be coordinated to the surfaces of the nanoparticles P, thereby stabilizing the dispersion.
[0047] (solvent) The solvent may be a low polarity solvent (low dielectric constant solvent) that has a dielectric constant equal to or less than a predetermined value. The predetermined value is preferably 6.0 or less, and more preferably 4.5 or less.
[0048] Specific examples of low polarity solvents include aromatic hydrocarbons such as xylene (dielectric constant 2.3) and toluene (dielectric constant 2.4); hydrocarbons such as hexane (dielectric constant 1.9); alicyclic hydrocarbons such as cyclohexane (dielectric constant 2.0); esters such as ethyl acetate (dielectric constant 6.0) and butyl acetate (dielectric constant 5.0); alkyl halides such as chloroform (dielectric constant 4.9); and ethers such as diethyl ether (dielectric constant 4.3). If necessary, these solvents can be mixed and used. In that case, the weighted average of the dielectric constants of the solvents is used.
[0049] (ligand) In this embodiment, the ligand 60 is preferably selected from at least one compound or ion selected from the group consisting of weak acids such as carboxylic acids, weak bases such as amines, and salts or ions thereof.
[0050] The acid may be, for example, a branched or straight chain fatty acid having 1 to 30 carbon atoms. The alkyl chain may be either saturated or unsaturated. Among them, from the viewpoint of solubility in a solvent and stability, a straight chain fatty acid is preferred, and oleic acid is more preferred.
[0051] The base may be, for example, a branched or linear organic base having 1 to 30 carbon atoms. The alkyl chain may be either saturated or unsaturated. Among them, from the viewpoint of solubility in a solvent and stability, a linear organic base is preferred, and oleylamine is more preferred.
[0052] The ligand 60 may be used alone or in combination of two or more kinds.
[0053] (Amount of ligand relative to nanoparticle P) The amount of the ligand, relative to the amount of nanoparticle P taken as 100, is preferably from 10 to 500, more preferably from 20 to 400, and even more preferably from 30 to 300. If the amount of the ligand is less than 10 or more than 300, the dispersion stability of the nanoparticle P may be insufficient.
[0054] (Associative ligand) In this embodiment, the associative ligand 60 includes an associative ligand having a main chain 40 containing multiple carbons and a polar group 50 that is more polar than the main chain 40, and self-associates in the solvent 10. The associative ligand 60 may be composed of a low molecular weight compound as shown in FIG. 2(b), or may be composed of a high molecular weight compound as shown in FIG. 2(c). It may also include both a low molecular weight compound and a high molecular weight compound (not shown). It may self-associate intramolecularly as shown in FIG. 2(c), or it may self-associate between molecules as shown in FIG. 2(d). In FIG. 2(b), the main chain 40 of the ligand 60 is shown as a straight chain, but the main chain 40 may be a branched skeleton.
[0055] From the viewpoint of more effectively inducing a change to the α phase, it is preferable that the material is mainly composed of a polymer compound.
[0056] The main chain 40 of the low molecular weight compound may be a linear, branched or cyclic alkyl group, a linear, branched or cyclic heteroalkyl group, an aryl group, a heteroaryl group, an aralkyl group or a heteroaralkyl group, some of which may further have a substituent.
[0057] The polar group 50 is composed of a strong acid such as sulfonic acid or phosphonic acid, a strong base such as a quaternary ammonium cation, or a zwitterionic group such as sulfobetaine, phosphobetaine, or carboxybetaine. The polar group 50 also includes a form selected from at least one compound or ion selected from the group consisting of the salts or ions that are the above-mentioned constituent elements.
[0058] As the polymer compound, a copolymer (described later) obtained by polymerizing at least two types of monomers can be used.
[0059] (Amount of associative ligand relative to nanoparticle P) The amount of the ligand when the nanoparticle P is 100 is preferably 1 to 1000, more preferably 10 to 800, and even more preferably 30 to 600. If the amount of the associative ligand is less than 10, the effect of forming a single phase may not be sufficiently obtained. If the amount of the associative ligand is more than 600, the association of the associative ligand may not be well formed in the solvent.
[0060] (mmol of polar groups per gram of nanoparticles P) The number of mmol of polar groups per 1 g of nanoparticles P is preferably 0.01 to 10, more preferably 0.03 to 8, and more preferably 0.1 to 6. When the number of mmol of polar groups per 1 g of nanoparticles P is within the above range, coordination to nanoparticles P proceeds rapidly, and the crystal phase tends to become a single phase. When it is less than 0.01, the crystal phase may not become a single phase sufficiently. When it is more than 10, associations may not be formed well in a low polarity medium. The number of mmol corresponds to the content of polar groups contained in 1 g of nanoparticles P, and is calculated by multiplying the number of mmol by 10. -3 This is the unit equivalent to mol.
[0061] <Method of producing nanoparticle composition> The method for purifying nanoparticles of the present invention will be described in detail below.
[0062] The purification method of the present invention comprises the following steps. A step of preparing nanoparticles (A) that contain a perovskite-type crystal structure as an allotrope and exhibit multiple crystal structures. preparing a ligand liquid (B) containing a solvent exhibiting a relative dielectric constant of a predetermined value or less, and an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity relative to the main chain, and which self-associates in the solvent; A step of contacting the nanoparticles P with the ligand liquid Q to prepare a nanoparticle dispersion liquid (C). The step of preparing the nanoparticle dispersion liquid R also includes a step of making the crystal structure of the nanoparticles into a single phase.
[0063] (Step of preparing nanoparticles P) The above-mentioned method is used for preparing the nanoparticles P. If necessary, excess ligands may be removed by centrifugation or the like.
[0064] (Step of preparing ligand liquid Q) To prepare the ligand liquid Q, the second ligand produced by the above-mentioned method may be dispersed in the second solvent 80. If necessary, the dispersion can be promoted by performing ultrasonic treatment, heat treatment, or the like.
[0065] (Step of preparing nanoparticle dispersion R) To prepare the nanoparticle dispersion liquid R, the nanoparticles P and the ligand liquid Q may be mixed. In this case, the ligand liquid Q may be mixed with the solid-phase nanoparticles P, or the ligand liquid Q may be mixed with a dispersion liquid in which the nanoparticles P are dispersed in a solvent. The dispersion solvent of the nanoparticles P may be the same as or different from the solvent of the ligand liquid Q. In addition, the dispersion solvent of the nanoparticles P preferably exhibits a relative dielectric constant of a predetermined value or less. The predetermined value is preferably 6.0 or less, more preferably 4.5 or less.
[0066] (Step of selectively increasing the ratio of the content of a specific crystal structure among a plurality of crystal structures) In this embodiment, the step of selectively increasing the ratio of the content of a predetermined crystal structure in the plurality of crystal structures preferably includes a step of making the crystal structure of the nanoparticles into a single phase. In addition, the step of selectively increasing the ratio of the content of a predetermined crystal structure in the plurality of crystal structures preferably includes a step of selectively increasing the ratio of the content of a predetermined crystal structure in the plurality of crystal structures. As shown in FIG. 1(b), the nanoparticle purification method 1000 includes a crystal structure confirmation method 2000 including steps S201 to S209. By executing steps S201 to S209, it is possible to confirm the change in the crystal structure of the nanoparticles P caused by the step of adjusting the nanoparticle dispersion liquid R.
[0067] (First acquisition step S203) The first obtaining step S203 includes a step of collecting a first solid content from the nanoparticles P obtained in step S103 and obtaining information about the crystal structure of the first solid content. The information about the crystal structure of the first solid content can be obtained by an analysis method such as a diffraction angle spectrum by X-ray diffraction or a halo pattern obtained by electron beam diffraction.
[0068] (Second acquisition step S205) The second acquisition step S205 includes a step of collecting a second solid content from the nanoparticle dispersion liquid and acquiring information about the crystal structure of the second solid content. The method of acquiring information about the crystal structure of the second solid content is similar to the method of acquiring information about the crystal structure of the first solid content, but it is preferable to make the method of acquiring information about the crystal structure of the second solid content the same as the method of acquiring information about the crystal structure of the first solid content.
[0069] (Step S207 for confirming changes in crystal structure) The step S207 of confirming the change in the crystal structure confirms the change in the crystal structure of the nanoparticles P due to the step of adjusting the nanoparticle dispersion liquid, based on the information regarding the crystal structure of the first solid content and the information regarding the crystal structure of the second solid content.
[0070] (multiple crystal structures) Next, a description will be given of the multiple crystal structures exhibited by the nanoparticles P prepared in step S103.
[0071] The multiple crystal structures include at least one of an α phase, a β phase, and a γ phase, and the predetermined crystal structure preferably includes an α phase. Here, the α phase is a crystal phase classified as a cubic crystal system. The β phase is a crystal phase classified as a tetragonal crystal system. The γ phase is a crystal phase classified as an orthorhombic crystal system. Among the α phase, β phase, and γ phase, the α phase is a high-temperature stable phase.
[0072] The plurality of crystal structures preferably includes a plurality of crystal structures having different synthesis temperatures, and the predetermined crystal structure preferably corresponds to a crystal structure having the highest synthesis temperature among the plurality of crystal structures.
[0073] The multiple crystal structures may also be AB2X5, A4BX6, etc. crystal structures.
[0074] In the step of converting the nanoparticles into a single-phase crystal structure, it is preferable to confirm the single-phase crystal structure of the nanoparticles by performing X-ray diffraction (XRD) measurement on each of the first solid content in which the nanoparticles P are deposited on a substrate and the second solid content in which the nanoparticle dispersion liquid R is deposited on a substrate. Specifically, the single-phase crystal structure can be confirmed by the signal being changed from a double peak or a broad overlapping peak observed in the β-phase and γ-phase to a single peak or a sharp peak.
[0075] The effect of the step of selectively increasing the ratio of the content of a predetermined crystal structure among a plurality of crystal structures can be confirmed by steps S203 and S205 shown in FIG. 1(b).
[0076] The first obtaining step S203 includes a step of collecting a first solid content from a part of the nanoparticles P and obtaining information on the crystal structure of the first solid content. The second obtaining step S205 includes a step of collecting a second solid content from a part of the nanoparticle dispersion R and obtaining information on the crystal structure of the second solid content.
[0077] Based on the information regarding the crystal structure of the first solid content and the information regarding the crystal structure of the second solid content, a confirmation step S207 confirms that the step of adjusting the mixed liquid R selectively increases the ratio of the content of a specified crystal structure among the multiple crystal structures.
[0078] In order to promote the formation of a single-phase crystal structure, it is preferable to carry out heating, ultrasonic treatment, etc. The heating temperature is preferably 30°C to 100°C, and more preferably 40°C to 80°C.
[0079] (Method of Producing Polymer Compound) A detailed description is given below of a method for producing a polymer compound that can be used as the associative ligand 60. The method for producing the polymer compound is not particularly limited as long as it can produce the above-mentioned structure, but it can be produced, for example, by the following method (i) or (ii).
[0080] That is, the method (i) for producing a polymer compound includes a method of producing a monomer having a structural unit containing a polar group, and then polymerizing the monomer to produce the polymer compound. Furthermore, the method (ii) for producing a polymer compound includes a method of synthesizing a polymer main chain, and then bonding a polar group to the polymer main chain.
[0081] From the viewpoints of easy availability of monomers and control of the amount of functional groups, the method shown in (i) is preferable. Hereinafter, a method for synthesizing a polymer compound containing a zwitterionic group as a polar group using the method shown in (i) will be described in detail.
[0082] As a monomer for introducing a polar group into a polymer compound, a vinyl ether derivative, an acrylate derivative, a methacrylate derivative, an α-olefin derivative, an aromatic vinyl derivative, etc. From the viewpoint of ease of production of the monomer, it is preferable to use an acrylate derivative or a methacrylate derivative as such a monomer.
[0083] The corresponding acrylate or methacrylate derivatives can be prepared by the methods described in the following documents. K. Ishihara and 2 others, "Polymer Journal" (Japan), The Society of Polymer Science, 1990, Vol. 22, p. 355-360.
[0084] The polymerization method of the above monomers includes radical polymerization and ionic polymerization, and living polymerization can also be used for the purpose of controlling the molecular weight distribution or structure. From an industrial perspective, it is preferable to use radical polymerization.
[0085] Radical polymerization can be carried out by using a radical polymerization initiator, irradiating with light such as radiation or laser light, using a photopolymerization initiator in combination with light irradiation, heating, etc. The radical polymerization initiator may be any that can generate radicals and initiate a polymerization reaction, and is selected from compounds that generate radicals by the action of heat, light, radiation, oxidation-reduction reactions, etc.
[0086] For example, azo compounds, organic peroxides, inorganic peroxides, organometallic compounds, photopolymerization initiators, etc. may be mentioned.
[0087] More specifically, examples of the initiator include azo compounds such as 2,2'-azobisisobutyronitrile (AIBN) and 2,2'-azobis(2,4-dimethylvaleronitrile), organic peroxides such as benzoyl peroxide (BPO), tert-butyl peroxypivalate, and tert-butylperoxyisopropyl carbonate, inorganic peroxides such as potassium persulfate and ammonium persulfate, and redox initiators such as hydrogen peroxide-iron(II) salt, BPO-dimethylaniline, and cerium(IV) salt-alcohol. Photopolymerization initiators include acetophenone, benzoin ether, and ketal. Two or more of these radical polymerization initiators may be used in combination.
[0088] The polymerization temperature of the vinyl monomer is not particularly limited and the preferred temperature range varies depending on the type of polymerization initiator used, but polymerization is generally carried out at a temperature of -30°C to 150°C, and a more preferred temperature range is 40°C to 120°C.
[0089] The amount of the polymerization initiator used in this case is preferably 0.1 to 20 parts by mass per 100 parts by mass of the monomer, and the amount used is preferably adjusted so as to obtain a polymer compound having a target molecular weight distribution.
[0090] The polymerization method is not particularly limited and may be any method such as solution polymerization, suspension polymerization, emulsion polymerization, dispersion polymerization, precipitation polymerization, and bulk polymerization.
[0091] The resulting polymer compound may be purified as necessary by any method, including, but not limited to, reprecipitation, dialysis, column chromatography, etc.
[0092] The structure of the produced polymer compound can be identified by various instrumental analyses, such as nuclear magnetic resonance (NMR), gel permeation chromatography (GPC), and inductively coupled plasma atomic emission spectrometry (ICP-AES).
[0093] (polymerizable compound) The polymerizable compound is a component that is accelerated in polymerization upon receiving energy such as light or heat, and imparts viscosity to the photoresponsive composition and hardens it. The polymerizable compound may be a radically polymerizable compound or a cationic polymerizable compound. These may be used alone or in combination of two or more. In addition, either a photopolymerizable compound or a thermally polymerizable compound may be used. In the present specification, the form in which the polymerizable compound is polymerized to increase the viscosity may be referred to as a polymer.
[0094] Examples of the radically polymerizable compound that can be used include monofunctional (meth)acrylate compounds, bifunctional (meth)acrylate compounds, trifunctional or higher (meth)acrylate compounds, hydroxyl group-containing (meth)acrylate compounds, carboxy group-containing (meth)acrylate compounds, and vinyl compounds.
[0095] Examples of monofunctional (meth)acrylates include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, butyl (meth)acrylate, hexyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, cyclohexyl (meth)acrylate, dicyclopentenyl (meth)acrylate, dicyclopentenyloxyethyl (meth)acrylate, benzyl (meth)acrylate, and 3,3,5-trimethylcyclohexyl acrylate. , tetrahydrofurfuryl (meth)acrylate, phenoxyethyl (meth)acrylate, methoxyethyl (meth)acrylate, ethyl carbitol (meth)acrylate, isobornyl (meth)acrylate, methoxytriethylene glycol (meth)acrylate, (2-methyl-2-ethyl-1,3-dioxolan-4-yl)methyl (meth)acrylate, (3-ethyloxetan-3-yl)methyl (meth)acrylate, and cyclic trimethylolpropane formal (meth)acrylate can be used.
[0096] Examples of bifunctional (meth)acrylate compounds include 1,4-butanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, 1,9-nonanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol 200 di(meth)acrylate, polyethylene glycol 300 di(meth)acrylate, polyethylene glycol 400 di(meth)acrylate, and polyethylene glycol 600. Di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, tetrapropylene glycol di(meth)acrylate, polypropylene glycol 400 di(meth)acrylate, polypropylene glycol 700 di(meth)acrylate, neopentyl glycol di(meth)acrylate, neopentyl glycol PO-modified di(meth)acrylate, EO-modified bisphenol A di(meth)acrylate, PO-modified bisphenol A di(meth)acrylate, and hydroxypivalic acid neopentyl glycol di(meth)acrylate can be used.
[0097] Examples of trifunctional or higher (meth)acrylate compounds that can be used include trimethylolpropane tri(meth)acrylate, trimethylolpropane EO-modified tri(meth)acrylate, trimethylolpropane PO-modified tri(meth)acrylate, glycerin propoxy tri(meth)acrylate, pentaerythritol tri(meth)acrylate, tris(acryloxyethyl)isocyanurate, and EO-modified pentaerythritol tetraacrylate.
[0098] Examples of the vinyl-based compound that can be used include vinyl acetate, vinyl benzoate, vinyl pivalate, vinyl butyrate, vinyl methacrylate, and N-vinylpyrrolidone.
[0099] The cationic polymerizable compound may be either a photopolymerizable or a thermally polymerizable compound. These may be used alone or in combination of two or more. Representative cationic polymerizable compounds include, for example, epoxy compounds, oxacene compounds, and vinyl ether compounds.
[0100] The amount of the polymerizable compound including the above radical polymerizable compound and cationic polymerizable compound used is preferably 1 to 99 parts by mass, more preferably 3 to 90 parts by mass, and even more preferably 5 to 80 parts by mass, relative to the total parts by mass of the photoresponsive composition.
[0101] (Polymerization initiator) In a polymerization reaction, a polymerization initiator and a polymerizable compound are generally used in combination. The polymerization initiator is a compound that generates an active species that initiates a polymerization reaction by irradiation with active energy rays or heat, and a known polymerization initiator can be used. The main active species that initiate a polymerization reaction include a radical polymerization initiator that generates a radical and a cationic polymerization initiator that generates an acid, and these may be used in combination. Examples of photoradical polymerization initiators that generate radicals by active energy rays include diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl methyl ketal, 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone, 1-hydroxycyclohexyl phenyl ketone, 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one, 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)butane, oligo[2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]butane, and oligo[2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]butane. acetophenones such as 2-hydroxy-1-[4-[4-(2-hydroxy-2-methylpropionyl)benzyl]phenyl]-2-methylpropan-1-one; benzoins such as benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether; phosphines such as 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide and bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide; and other phenyl glyoxylic methyl esters.
[0102] Among the photoradical polymerization initiators, acetophenones such as aminoketones, phosphines, and oxime ester compounds are preferred. These can be used alone or in combination depending on the properties required for the cured product. When using a radical polymerization initiator, the amount used is preferably 0.01 to 100 parts by mass, more preferably 0.1 to 50 parts by mass, based on 100 parts by mass of the total solid content in the composition.
[0103] (Other additives) In this embodiment, the light-responsive composition may be used in combination with an oxygen remover, an antioxidant, a scattering agent such as titanium oxide, a surfactant, an anti-mold agent, a light stabilizer, or other additives that impart various properties, a diluting solvent, etc., as necessary.
[0104] <Second embodiment> A nanoparticle composition 100 according to a second embodiment will be described with reference to FIG.
[0105] The nanoparticle composition 100 according to the second embodiment comprises nanoparticles 110 having a perovskite crystal structure as an allotrope, and associating ligands 140 having a main chain 120 containing a plurality of carbons and a polar group 130 having a higher polarity than the main chain. At least a portion of the associating ligands 140 is coordinated to the nanoparticles 110 via the polar group 130 so as to change the crystal structure of the nanoparticles.
[0106] (Nanoparticles) The nanoparticles 110 in this embodiment are nanoparticles that contain nanocrystals having a perovskite crystal structure as allotropes, with the A site (monovalent cation), the B site (divalent cation), and the X site (monovalent anion including a halide anion) as constituents. Each constituent may be the same as that of the nanoparticles P shown in the first embodiment.
[0107] (Associative ligand) In this embodiment, the associating ligand 140 has a main chain 120 containing multiple carbon atoms and a polar group 130 that is more polar than the main chain. Also, the associating ligand 140 is coordinated to the nanoparticle 110 via the polar group 130 so as to change the crystal structure of the nanoparticle 110.
[0108] The associating ligand 140 may be composed of a low molecular weight compound as shown in Fig. 3(a) or may be composed of a high molecular weight compound as shown in Fig. 2(b), or may contain both a low molecular weight compound and a high molecular weight compound (not shown).
[0109] From the viewpoint of more effectively inducing a change to the α phase, it is preferable that the material is mainly composed of a polymer compound.
[0110] The main chain 120 of the low molecular weight compound may be a linear, branched or cyclic alkyl group, a linear, branched or cyclic heteroalkyl group, an aryl group, a heteroaryl group, an aralkyl group or a heteroaralkyl group, some of which may further have a substituent.
[0111] The polar group 130 is at least one selected from the group consisting of strong acids such as sulfonic acid and phosphonic acid, strong bases such as quaternary ammonium cations, zwitterionic groups such as sulfobetaine, phosphobetaine, and carboxybetaine, and salts or ions thereof.
[0112] As the polymer compound, a copolymer obtained by polymerizing at least two kinds of monomers can be used.
[0113] <Third embodiment> The nanoparticle composition according to the second embodiment will be described with reference to FIG.
[0114] The nanoparticle composition according to the third embodiment includes a solvent 201 having a relative dielectric constant equal to or less than a predetermined value, Nanoparticles 210 having a perovskite crystal structure as an allotrope; A main chain 220 containing a plurality of carbon atoms and a plurality of ligands 240 having polar groups 230 that are more polar than the main chain, The plurality of ligands 240 are a first component 250 that forms a reverse micelle-like structure in a solvent 201; and a second component 260 coordinated to the particle surface of the nanoparticle.
[0115] The plurality of ligands 240 may be composed of low molecular weight compounds as shown in Fig. 4(a) or may be composed of high molecular weight compounds as shown in Fig. 4(b), or may contain both low molecular weight compounds and high molecular weight compounds (not shown).
[0116] From the viewpoint of more effectively inducing a change to the α phase, it is preferable that the material is mainly composed of a polymer compound.
[0117] The main chain 210 of the low molecular weight compound may be a linear, branched or cyclic alkyl group, a linear, branched or cyclic heteroalkyl group, an aryl group, a heteroaryl group, an aralkyl group or a heteroaralkyl group, some of which may further have a substituent.
[0118] As the polar group 230, at least one selected from the group consisting of strong acids such as sulfonic acid and phosphonic acid, strong bases such as quaternary ammonium cations, zwitterionic groups such as sulfobetaine, phosphobetaine, and carboxybetaine, and salts or ions thereof is used.
[0119] As the polymer compound, a copolymer obtained by polymerizing at least two kinds of monomers can be used.
[0120] (reverse micelle-like structure) In this embodiment, the reverse micelle-like structure is a structure formed by at least some of the polar groups 230 associating with each other through electrostatic interaction in a solvent 201 exhibiting a specific dielectric constant or less. The polar groups 230 do not necessarily have to interact directly with each other, and a small amount of polar substance such as water may be present between them. The association may be an intermolecular association or an intramolecular association. Different types of polar groups may be associated with each other through electrostatic interaction.
[0121] <Fourth embodiment> The nanoparticle compositions 100, 200 having flowability exhibit the effect of the present invention of maintaining the α phase even when the nanoparticle compositions 100, 200 are cured on a substrate. The nanoparticle composition 200 (100) is in the form of a layer supported by another member, and may be referred to as a wavelength conversion layer. Support forms include a laminated form and a dispersed form dispersed in a matrix material. Examples of the wavelength conversion layer include a nanoparticle composition coated on a support member (substrate) and cured to form a film, sheet, or patterned pixels.
[0122] FIG. 5 shows a cross-sectional structure of a display element 400 according to the fourth embodiment.
[0123] The display element 400 has a light-emitting layer 410, a dielectric multilayer film 417, and a wavelength conversion layer 420 stacked in a stacking direction D1. The downstream side in the stacking direction D1 corresponds to the side where a user who views an image drawn on the display element is positioned. The wavelength conversion layer 420 is separated from the wavelength conversion layers corresponding to adjacent elements by a black matrix BM that separates the pixels.
[0124] As described above, the nanoparticle composition 200 is in a form containing a polymerizable monomer (not shown). The nanoparticle composition 200 containing the polymerizable monomer is cured together with the polymerizable compound by carrying out a polymerization process such as a photopolymerization process. The nanoparticle composition 200 is cured to become a solid nanoparticle composition 426 supported by the dielectric multilayer film 417. The nanoparticle composition 426 is configured to satisfy a predetermined dimension and constitutes the wavelength conversion layer 420 of the display element 400. In other words, the wavelength conversion layer 420 is a layer in which the nanoparticle composition 200 is solidified by being cured in its entirety together with the polymerizable compound 150.
[0125] The light emitting layer 410 corresponds to a light source that emits light L1 of a first wavelength λ1. The wavelength conversion layer 420 has an optical coupling surface 422 that is optically coupled to the light emitting layer 410 on the side of the light emitting layer 410, and has an extraction surface 424 on the opposite side of the light emitting layer 410 that is converted by the wavelength conversion layer 420 and extracts the secondary light L2.
[0126] The wavelength conversion layer 420 of this embodiment receives primary light L1 of wavelength λ1 propagating through the dielectric multilayer film 417. The dielectric multilayer film 417 provides the display element 400 with the spectral transmission characteristics of the primary light from the light emitting layer 410 and the spectral reflection characteristics of secondary light L2 of wavelength λ2 emitted in the wavelength conversion layer 420. The wavelength λ2 of the secondary light L2 is longer than the wavelength λ1 of the primary light L1.
[0127] The dielectric multilayer film 417 can be replaced with another optical member having optical transparency to the first wavelength λ1 emitted by the light emitting layer 410. In addition, another optical member (not shown) can be disposed in front of the extraction surface 424 (opposite side to the light emitting layer 410).
[0128] (Method of forming wavelength conversion layer) The method for forming the wavelength conversion layer 420 is not particularly limited, and may be, for example, a method in which a nanoparticle composition is applied onto a substrate, and then pre-dried as necessary, and further, as necessary, heated or irradiated with active energy rays to harden the film. The thickness of the hardened wavelength conversion layer 420 is preferably 0.1 to 200 μm, more preferably 1 to 100 μm.
[0129] The active energy ray in the active energy ray irradiation is appropriately selected from electromagnetic waves such as heat rays, ultraviolet rays, visible rays, near infrared rays, and electron beams that reduce fluidity and promote curing through polymerization, crosslinking, drying, etc. As a light source for applying active energy rays, a light source having a main wavelength of emission in the wavelength region of 100 to 450 nm is preferable. Examples of such light sources include ultra-high pressure mercury lamps, high pressure mercury lamps, medium pressure mercury lamps, mercury xenon lamps, metal halide lamps, high power metal halide lamps, xenon lamps, pulsed xenon lamps, deuterium lamps, fluorescent lamps, ND-YAG triple wave lasers, HE-CD lasers, nitrogen lasers, XE-Cl excimer lasers, XE-F excimer lasers, semiconductor pumped solid state lasers, and LED lamp light sources having emission wavelengths of 365 nm, 375 nm, 385 nm, 395 nm, and 405 nm.
[0130] ((Measurement method)) The various physical property measurements can be carried out as follows.
[0131] ((Molecular weight distribution measurement)) The molecular weight distribution of the polymer compound can be calculated in terms of monodisperse polymethyl methacrylate by gel permeation chromatography (GPC). Measurement of the molecular weight by GPC can be carried out, for example, as follows.
[0132] The sample is added to the eluent below so that the sample concentration becomes 1% by mass, and the solution is left to stand at room temperature for 24 hours to dissolve. The solution is then filtered through a solvent-resistant membrane filter with a pore size of 0.45 μm to obtain the sample solution, which is then measured under the following conditions. Apparatus: Agilent 1260 infinity system (Agilent Technologies) Column: PFG analytical linear M columns (PSS) Eluent: 2,2,2-trifluoroethanol Flow rate: 0.2ml / min Oven temperature: 40℃ Sample injection volume: 20 μL
[0133] In calculating the molecular weight distribution of the sample, a molecular weight calibration curve prepared using a standard polymethyl methacrylate resin (EasiVial PM Polymer Standard Kit manufactured by Agilent Technologies) is used.
[0134] ((Structural analysis of associative ligands)) The structural analysis of the associative ligand can be carried out using nuclear magnetic resonance (NMR). For example, 1H-NMR and 13C-NMR spectrum measurements are performed using an ECA-600 (600 MHz) manufactured by JEOL Ltd. The measurements are performed at 25°C in a deuterated solvent containing tetramethylsilane as an internal standard. The chemical shift value is read as a ppm shift value (δ value) with the internal standard tetramethylsilane set to 0.
[0135] ((Method for confirming that associative ligands are coordinated to nanoparticles)) Whether or not the associative ligand 60 is coordinated to the nanoparticle P can be confirmed by using nuclear magnetic resonance (NMR). For example, using ECA-600 (600 MHz) manufactured by JEOL Ltd., 1 H-NMR measurement is performed. 1 Coordination can be confirmed by the fact that the δ value of the H signal shifts from the δ value for the associative ligand alone and the half-width changes.
[0136] ((Analysis of the association state of associative ligands)) The association state of the associative ligand can be analyzed by NMR or dynamic light scattering (DLS). When NMR is used, for example, 1H-NMR is measured using ECA-600 (600MHz) manufactured by JEOL Ltd. When there is association, the chemical shift value of the polar group signal changes from the value in the non-associated state. When there is association, the movement of the molecule is restricted, so the spectrum is observed to be broadened overall. If necessary, it is also possible to analyze the association state in more detail by performing relaxation time measurement. When DLS is used, the association state can be analyzed from the particle size. When the associative ligand forms a large structure by intermolecular association, a particle size of about several hundred nm is observed. When there is intramolecular association, a particle size of about several nm is observed.
[0137] ((Crystal structure (crystal phase) analysis of nanoparticles)) The crystal structure (crystal phase) and composition of nanoparticles can be analyzed using X-ray diffraction (XRD). For example, the X-ray diffraction pattern can be measured using a RINT 2100 (Rigaku) and compared with a diffraction pattern in a database to analyze the crystal structure and composition. Depending on the shape and size of the sample, electron diffraction (ED) accompanying a cross-sectional TEM may be used.
[0138] ((How to check if it has been converted to single phase)) The change in the crystal structure (crystal phase) of the nanoparticles to a single phase can be confirmed from the change in the XRD signal. For example, nanoparticles exhibiting the γ phase have a large half-width due to the overlap of two signals at a diffraction angle (2θ) of around 30°, but when they change to the α phase, the half-width becomes smaller.
[0139] ((Nanoparticle Composition Analysis)) The composition of the nanoparticles can also be analyzed by XPS and ICP emission spectroscopy. The molar ratio of A and B can be measured from the signal intensity of XPS, and the concentration of X can be measured from the emission intensity of ICP emission spectroscopy (for example, CIROS CCD (SPECTRO)).
[0140] ((Amount of ligand and associative ligand relative to nanoparticle P)) The amount of the ligand relative to the amount of the nanoparticle P can be determined by TG-DTA measurement and NMR measurement. For example, the amount of the nanoparticle P in the nanoparticle composition is measured by TG-DTA measurement. Next, the amount of the ligand and the amount of the associative ligand in the nanoparticle composition are determined by NMR measurement, respectively, so that the amount of the ligand and the amount of the associative ligand relative to the nanoparticle P can be determined.
[0141] ((Amount of polar groups in the associating ligand)) The amount of polar groups in the associating ligand can be determined by NMR measurement. For example, 1H-NMR is measured using ECA-600 (600 MHz) manufactured by JEOL Ltd. The amount of polar groups in the associating ligand is calculated by comparing the signal intensity derived from the polar groups with the signal intensity derived from other parts.
[0142] ((mmol of polar groups per gram of nanoparticles)) The number of mmoles of polar groups per 1 g of nanoparticles can be calculated from the amount of nanoparticles P determined by the above method, the amount of associating ligand, and the amount of polar groups in the associating ligand. EXAMPLES
[0143] The present disclosure will be described in more detail below with reference to examples, but the present disclosure is not limited thereto.
[0144] [Preparation of associative ligand a] A reaction vessel equipped with a cooling tube, a stirrer, a thermometer, and a nitrogen inlet tube was prepared. 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid, 51.1 parts of hexyl methacrylate, 3.9 parts of azobisisobutyronitrile, and 900 parts of 2,2,2-trifluoroethanol were charged into the reaction vessel. Nitrogen bubbling was then performed for 30 minutes into the reaction vessel. The resulting reaction mixture was heated at 65°C for 8 hours under a nitrogen atmosphere to complete the polymerization reaction. After cooling the reaction liquid to room temperature, 300 parts of water were added to precipitate the product. After centrifugation, the supernatant was removed. After distilling off the solvent under reduced pressure, the mixture was dried under reduced pressure at 50°C and 0.1 kPa or less to obtain an associative ligand a. It was confirmed by NMR measurement that the structural unit having a polar group was contained in 1 mol% of the total monomer units. In addition, GPC analysis revealed that the weight average molecular weight (Mw) was 12,500.
[0145] [Preparation of associative ligand b] Associative ligand b was produced in the same manner as associative ligand a, except that in the production of associative ligand a, the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 5.9 parts, and the amount of hexyl methacrylate was changed from 51.1 parts to 48.0 parts.
[0146] [Preparation of associative ligand c] Associative ligand c was produced in the same manner as associative ligand a, except that in the production of associative ligand a, the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 6.8 parts, and the amount of hexyl methacrylate was changed from 51.1 parts to 47.5 parts.
[0147] [Preparation of associative ligand d] Associative ligand d was produced in the same manner as for associative ligand a, except that in the production of associative ligand a, the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 10.2 parts, and the amount of hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0148] [Preparation of associative ligand e] Associative ligand e was produced in the same manner as associative ligand a, except that in the production of associative ligand a, the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 15.2 parts, and the amount of hexyl methacrylate was changed from 51.1 parts to 42.3 parts.
[0149] [Preparation of associative ligand f] Associative ligand f was produced in the same manner as for associative ligand a, except that in the production of associative ligand a, the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 20.3 parts, and the amount of hexyl methacrylate was changed from 51.1 parts to 39.2 parts.
[0150] [Preparation of associative ligand g] Associative ligand g was produced in the same manner as for associative ligand a, except that in the production of associative ligand a, the amount of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed from 0.8 parts to 33.9 parts, and the amount of hexyl methacrylate was changed from 51.1 parts to 31.0 parts.
[0151] [Preparation of associative ligand h] Associative ligand h was produced in the same manner as in the production of associative ligand a, except that in the production of associative ligand a, 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed to 10.7 parts of 2-(methacryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, and hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0152] [Preparation of associative ligand i] Associative ligand i was produced in the same manner as in the production of associative ligand a, except that in the production of associative ligand a, 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed to 7.8 parts of 2-[[2-(methacryloyloxy)ethyl]dimethylammonio]acetic acid, and hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0153] [Preparation of associative ligand j] In a reaction vessel equipped with a cooling tube, a stirrer, a thermometer and a nitrogen inlet tube, 7.6 parts of [2-(methacryloyloxy)ethyl]trimethylammonium chloride (80% aqueous solution), 45.4 parts of hexyl methacrylate, 3.9 parts of azobisisobutyronitrile and 900 parts of n-butanol were charged, and nitrogen bubbling was performed for 30 minutes. The resulting reaction mixture was heated at 65°C for 8 hours under a nitrogen atmosphere to complete the polymerization reaction. After cooling the reaction liquid to room temperature, 300 parts of water were added to precipitate the product. After centrifugation, the supernatant was removed. After distilling off the solvent under reduced pressure, the mixture was dried under reduced pressure at 50°C and 0.1 kPa or less. 5 parts of the obtained solid was dissolved in 95 parts of tetrahydrofuran, and a solution in which 1.3 parts of sodium bromide was dissolved in 2.7 parts of water was slowly added, and the mixture was stirred at room temperature for 2 hours. The resulting liquid was reprecipitated with water, washed with methanol, and then vacuum dried at 50°C for 6 hours to produce associative ligand j.
[0154] [Preparation of associative ligand k] Associative ligand k was produced in the same manner as in the production of associative ligand a, except that in the production of associative ligand a, 0.8 parts of 3-[[2-(methacryloyloxy)ethyl]dimethylammonio]propane-1-sulfonic acid was changed to 3.1 parts of methacrylic acid, and hexyl methacrylate was changed from 51.1 parts to 45.4 parts.
[0155] [Preparation of associative ligand l] As the associating ligand l, octadecyldimethyl(3-sulfopropyl)ammonium hydroxide inner salt (Tokyo Chemical Industry Co., Ltd.) was prepared.
[0156] The structures, compositions, and molecular weights of the produced and prepared associative ligands a to k are shown in Table 1.
[0157] [Table 1]
[0158] [Preparation of association solution] (Association solution of associative ligand a in toluene) In a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, 1 part of associative ligand a and 99 parts of toluene were charged, and the temperature was raised to 110°C and heated for 5 minutes. After confirming that associative ligand d was completely dissolved, the mixture was cooled to room temperature to obtain an association solution a of associative ligand a in toluene.
[0159] (Association solution of associative ligands b to l in toluene) Except for using associative ligands b to l instead of associative ligand a, association solutions b to l of polymer compounds b to l in toluene were prepared in the same manner as for the association solution in toluene of associative ligand a.
[0160] (Association solution of associative ligand d in hexane) In a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, 1 part of associative ligand d and 99 parts of hexane were charged, heated to 60°C, and heated for 5 minutes. The mixture was cooled to room temperature to obtain an association liquid d-2 of associative ligand d in hexane.
[0161] (Association solution of associative ligand d in chloroform) In a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, 1 part of associative ligand d and 99 parts of chloroform were charged, heated to 60°C, and heated for 5 minutes. The mixture was cooled to room temperature to obtain an association liquid d-3 of associative ligand d in chloroform.
[0162] (Association solution of associative ligand d in ethyl acetate) In a reaction vessel equipped with a stirrer, a thermometer, and a reflux condenser, 1 part of associative ligand d and 99 parts of ethyl acetate were charged, heated to 70°C, and heated for 5 minutes. The mixture was cooled to room temperature to obtain an association liquid d-4 of associative ligand d in ethyl acetate.
[0163] [Production of nanoparticles P-1] 10 parts of cesium carbonate, 27 parts of oleic acid, and 385 parts of 1-octadecene were placed in a flask, heated to 120°C, and degassed with a vacuum pump for 30 minutes. The mixture was further heated to 150°C under a dry nitrogen stream and held for 30 minutes to obtain a cation raw material liquid.
[0164] Separately, 10 parts of lead(II) bromide and 494 parts of 1-octadecene were placed in a flask, heated to 120°C, and degassed with a vacuum pump for 1 hour. 89 parts of oleic acid and 31 parts of oleylamine were added, and the mixture was degassed with a vacuum pump for 30 minutes. The nitrogen flow was then replaced and the liquid temperature was raised to 185°C.
[0165] 40 parts of the cation source liquid was added, and after 5 seconds, the mixture was cooled on ice. 2,000 parts of ethyl acetate was added, and the mixture was centrifuged to remove the supernatant. The resulting residue was dispersed in toluene to adjust the solid concentration to 1 wt%, yielding a dispersion of nanoparticles P-1 having a perovskite crystal structure of CsPbBr3. The ratio of nanoparticles P in the solid content measured by TG-DTA was 53 wt%. When XRD was measured, a signal derived from the γ phase of CsPbBr3 and a signal derived from CsPb2Br5 were observed.
[0166] [Production of nanoparticles P-2] A dispersion of nanoparticles P-2 having a perovskite crystal structure of CsPb(Br / I)3 was obtained in the same manner as in the luminescent nanocrystal dispersion a, except that 3.2 parts of lead(II) bromide and 9.3 parts of lead(II) iodide were used instead of 10 parts of lead(II) bromide. The ratio of nanoparticles P in the solid content measured by TG-DTA was 52 wt%. When XRD was measured, a signal derived from the γ phase of CsPb(Br / I)3 was observed.
[0167] [Production of nanoparticles P-3] Nanoparticles P-3 having a perovskite crystal structure of CsPbBr3 were produced in the same manner as nanoparticles P-1, except that the liquid temperature was set to 220°C. The ratio of nanoparticles P in the solid content measured by TG-DTA was 55 wt%. When XRD was measured, signals derived from the α-phase and γ-phase of CsPbBr3 were observed.
[0168] Example 1 100 parts of the dispersion a of nanoparticles P-1 was placed in a container, and the solvent was distilled off under reduced pressure. 100 parts of the association solution a of the associative ligand a in toluene was added, and ultrasonic treatment was performed for 20 minutes to promote changes in coordination and crystal phase, thereby obtaining nanoparticle composition 100-1.
[0169] (Examples 2 to 16, Comparative Examples 1 to 4) Nanoparticle compositions 100-2 to 100-20 were obtained in the same manner as in Example 1, except that the types of nanoparticles P, associating ligands, and associating liquid were changed as shown in Table 2.
[0170] [Table 2]
[0171] [evaluation] [Evaluation of crystal phase immediately after treatment] Immediately after the treatment, 50 μL of each liquid was placed in a sample holder to remove the solvent, and XRD measurement was performed. When nanoparticles P-1 were used, the half-width of the signal having a maximum value in the range of diffraction angles (2θ) of 30° to 31° was measured, and when nanoparticles P-2 were used, the half-width of the signal having a maximum value in the range of diffraction angles (2θ) of 28° to 30° was measured. The evaluation criteria are as follows. <Evaluation criteria> A: Half-width is 0.85° or less B: Half-width is greater than 0.85° and less than 0.9° C: Half-width is greater than 0.9° and less than 0.98° D: Half-width is greater than 0.98°
[0172] [Evaluation of crystal phase after aging] The sample holder after the crystal phase evaluation immediately after the treatment was left in a draft for one week, and then XRD measurement was performed again. When nanoparticles P-1 were used, the half-width of the signal having a maximum value in the range of diffraction angles (2θ) of 30° to 31° was measured, and when nanoparticles P-2 were used, the half-width of the signal having a maximum value in the range of diffraction angles (2θ) of 28° to 30° was measured. The evaluation criteria are as follows. <Evaluation criteria> A: Half-width is 0.85° or less B: Half-width is greater than 0.85° and less than 0.9° C: Half-width is greater than 0.9° and less than 0.98° D: Half-width is greater than 0.98°
[0173] The evaluation results are shown in Table 3.
[0174] [Table 3]
[0175] According to Table 3, the nanoparticle compositions 100-1 to 16 according to Examples 1 to 16 have a single-phase crystal phase immediately after the treatment, compared to the nanoparticle compositions 100-17 to 19 according to Comparative Examples 1 to 3. The crystal phase is also single-phase after aging. These results are considered to be due to the fact that the associative ligand 60 is coordinated to the nanoparticles P having a perovskite structure in the low polarity solvent 10, resulting in a single-phase crystal phase. Note that the nanoparticle composition 20 containing the nanoparticles P-3 synthesized at high temperature has an α-phase crystal phase immediately after the treatment, but cannot maintain the α-phase over time. [Explanation of symbols]
[0176] 1000 Method for producing nanoparticle composition (method for purifying nanoparticles) S103: Preparing nanoparticles exhibiting multiple crystal structures S105: A process for preparing a ligand solution S107: A process for preparing a nanoparticle dispersion S109: A process for selectively increasing the ratio of the content of a specific crystal structure among a plurality of crystal structures (a process for making the crystal structure of nanoparticles into a single phase)
Claims
1. preparing nanoparticles having a perovskite-type crystal structure as an allotrope and exhibiting a plurality of crystal structures; A step of preparing a ligand liquid including a solvent exhibiting a relative dielectric constant of a predetermined value or less, and an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity relative to the main chain, and self-associating in the solvent; contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion. A method for purifying nanoparticles, wherein the step of adjusting the nanoparticle dispersion liquid includes a step of selectively increasing a ratio of a content of a predetermined crystal structure among the plurality of crystal structures.
2. The method for purifying nanoparticles according to claim 1 , wherein the step of selectively increasing the ratio of the content of a specific crystal structure among the plurality of crystal structures includes a step of converting the crystal structure of the nanoparticles into a single phase.
3. A method for purifying nanoparticles as described in claim 1 or 2, wherein the process of selectively increasing the ratio of the content of a specified crystal structure among the multiple crystal structures includes a process of selectively increasing the ratio of the content of a specified crystal structure among the multiple crystal structures.
4. The plurality of crystal structures include at least one of an α phase, a β phase, and a γ phase, The method for purifying nanoparticles according to claim 2 or 3, wherein the predetermined crystal structure includes an α-phase.
5. The plurality of crystal structures include a plurality of crystal structures having different synthesis temperatures, The method for purifying nanoparticles according to claim 2 or 3, wherein the predetermined crystal structure corresponds to the crystal structure having the highest synthesis temperature among the plurality of crystal structures.
6. a first obtaining step of extracting a first solid content from the nanoparticles and obtaining information about a crystal structure of the first solid content; The method for purifying nanoparticles according to claim 1 or 2, further comprising a second acquisition step of collecting a second solid content from the nanoparticle dispersion and acquiring information regarding the crystal structure of the second solid content.
7. The method for purifying nanoparticles described in claim 6, further comprising a step of confirming a change in the crystal structure of the nanoparticles due to the step of adjusting the nanoparticle dispersion liquid based on information regarding the crystal structure of the first solid content and information regarding the crystal structure of the second solid content.
8. 3. The method for purifying nanoparticles according to claim 1, wherein the polar group comprises at least one selected from the group consisting of a strong acid, a strong base, a zwitterionic group, and salts or ions thereof.
9. 3. The method for purifying nanoparticles according to claim 1, wherein the polar group contains at least one selected from the group consisting of sulfonic acid, phosphonic acid, a quaternary ammonium cation, sulfobetaine, phosphobetaine, and carboxybetaine.
10. preparing nanoparticles having a perovskite-type crystal structure as an allotrope and exhibiting a plurality of crystal structures; A step of preparing a ligand liquid including a solvent exhibiting a relative dielectric constant of a predetermined value or less, and an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity relative to the main chain, and self-associating in the solvent; contacting the nanoparticles with the ligand liquid to prepare a nanoparticle dispersion; The process for preparing the nanoparticle dispersion includes a process for selectively increasing a ratio of a content of a predetermined crystal structure among the plurality of crystal structures.
11. The method for producing a nanoparticle composition according to claim 10, further comprising the step of adding a polymerizable compound to the nanoparticle dispersion.
12. Nanoparticles containing a perovskite crystal structure as an allotrope; an associative ligand having a main chain containing a plurality of carbon atoms and a polar group having polarity greater than that of the main chain; A nanoparticle composition, wherein at least a portion of the associative ligands are coordinated to the nanoparticles via the polar groups so as to alter the crystal structure of the nanoparticles.
13. A solvent having a relative dielectric constant equal to or less than a predetermined value; Nanoparticles containing a perovskite crystal structure as an allotrope; A main chain containing a plurality of carbon atoms and a plurality of ligands having polar groups that are more polar than the main chain, The plurality of ligands include a first component that forms a reverse micelle-like structure in the solvent; and a second component coordinated to the particle surface of the nanoparticle.
